tiprankstipranks
Trending News
More News >
Opus Genetics (IRD)
NASDAQ:IRD
US Market

Opus Genetics (IRD) Income Statement

Compare
1,022 Followers

Opus Genetics Income Statement

Last quarter (Q4 2024), Opus Genetics's total revenue was $4.30M, an increase of 154.41% from the same quarter last year. In Q4, Opus Genetics's net income was $-35.13M. See Opus Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Gross Profit
$ 10.99M$ 19.05M$ 39.85M$ 589.00K$ 0.00
Operating Expenses
$ 73.07M$ 29.61M$ 21.62M$ 23.29M$ 19.97M
Depreciation and Amortization
$ 10.00K$ 6.00K$ 4.00K$ 4.00K$ 8.00K
EBITDA
$ -57.52M$ -9.97M$ 18.22M$ -56.69M$ -17.77M
Operating Income
$ -62.07M$ -10.56M$ 18.23M$ -22.70M$ -19.97M
Other Income/Expenses
$ 4.54M$ 589.00K$ -23.00K$ -33.99M$ -4.65M
Pretax Income
$ -57.53M$ -9.97M$ 18.20M$ -56.69M$ -24.62M
Net Income
$ -57.53M$ -9.99M$ 17.89M$ -56.69M$ -24.62M
Per Share Metrics
Basic EPS
$ -2.15$ -0.46$ 0.90$ -3.82$ -5.28
Diluted EPS
$ -2.15$ -0.46$ 0.87$ -3.82$ -5.28
Weighted Average Shares Outstanding
26.72M 21.59M 19.93M 14.85M 4.66M
Weighted Average Shares Outstanding (Diluted)
26.72M 21.59M 20.60M 14.85M 4.66M
Currency in USD

Opus Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis